ImmunityBio Quarterly Balance Sheets Chart
Quarterly
|
Annual
ImmunityBio Quarterly Balance Sheets Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||||||||||||||||||||||||||||||
current assets: | |||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents | 137,658,000 | 60,660,000 | 143,428,000 | 111,966,000 | 130,104,000 | 133,035,000 | 265,453,000 | 177,963,000 | 43,506,000 | 88,481,000 | 104,641,000 | 104,161,000 | 61,900,000 | 36,385,000 | 181,101,000 | 64,524,000 | 83,958,000 | 44,679,000 | 11,441,000 | 27,688,000 | 102,698,000 | 16,952,000 | 15,508,000 | 18,291,000 | 17,279,000 | 22,279,000 | 16,821,000 | 15,310,000 | 16,122,000 | 11,196,000 | 23,872,000 | 20,920,000 | 39,039,000 | 13,596,000 | 8,083,000 | 31,404,000 | 38,223,000 | 63,250,000 | 175,908,000 | 358,616,000 | 120,437,000 |
marketable securities | 16,000,000 | 931,000 | 6,381,000 | 18,401,000 | 87,875,000 | 37,460,000 | 1,009,000 | 11,833,000 | 2,448,000 | 2,787,000 | 2,543,000 | 6,896,000 | 21,038,000 | 155,947,000 | 136,015,000 | 15,848,000 | 19,970,000 | 38,594,000 | 104,280,000 | 131,347,000 | 136,466,000 | 177,374,000 | 190,838,000 | 177,852,000 | 175,540,000 | 158,509,000 | 118,310,000 | ||||||||||||||
accounts receivable | 22,126,000 | 17,029,000 | 2,360,000 | 4,175,000 | 1,033,000 | 45,000 | |||||||||||||||||||||||||||||||||||
inventories | 6,640,000 | 8,444,000 | 8,272,000 | 1,958,000 | 1,811,000 | ||||||||||||||||||||||||||||||||||||
due from related parties | 204,000 | 424,000 | 293,000 | 729,000 | 1,027,000 | 2,137,000 | 2,019,000 | 2,325,000 | 2,025,000 | 1,464,000 | 1,890,000 | 1,488,000 | 1,451,000 | 3,893,000 | 1,333,000 | 1,304,000 | 2,047,000 | 2,057,000 | 86,000 | 90,000 | 107,000 | 54,000 | 55,000 | 154,000 | 61,000 | 79,000 | 82,000 | 1,089,000 | |||||||||||||
prepaid expenses and other current assets | 23,270,000 | 19,646,000 | 23,852,000 | 25,921,000 | 20,980,000 | 23,090,000 | 25,603,000 | 22,961,000 | 18,846,000 | 20,754,000 | 31,503,000 | 30,547,000 | 30,601,000 | 16,116,000 | 15,898,000 | 12,776,000 | 7,756,000 | 14,242,000 | 9,285,000 | 8,977,000 | 4,664,000 | 3,910,000 | 4,105,000 | 5,556,000 | 2,746,000 | 13,595,000 | 13,810,000 | 16,432,000 | 4,734,000 | 4,958,000 | 4,152,000 | 4,525,000 | 5,973,000 | 4,896,000 | 5,135,000 | 5,215,000 | 3,776,000 | 1,671,000 | 388,000 | ||
prepaid expenses – related parties | 2,234,000 | 2,029,000 | |||||||||||||||||||||||||||||||||||||||
total current assets | 208,132,000 | 109,163,000 | 184,586,000 | 163,150,000 | 242,830,000 | 195,722,000 | 294,084,000 | 215,082,000 | 66,825,000 | 113,486,000 | 140,577,000 | 143,092,000 | 114,990,000 | 212,341,000 | 334,347,000 | 94,452,000 | 113,731,000 | 99,572,000 | 75,498,000 | 98,018,000 | 115,287,000 | 44,125,000 | 55,757,000 | 71,613,000 | 87,048,000 | 113,430,000 | 88,772,000 | 100,570,000 | 110,093,000 | 126,802,000 | 132,458,000 | 156,853,000 | 181,557,000 | 195,948,000 | 205,145,000 | 214,471,000 | 217,959,000 | 225,535,000 | 297,540,000 | 360,287,000 | 120,870,000 |
property, plant and equipment | 133,004,000 | 135,270,000 | 137,094,000 | 139,285,000 | 141,956,000 | 143,517,000 | 146,082,000 | 152,000,000 | 151,487,000 | 154,165,000 | 143,659,000 | 130,441,000 | 119,445,000 | 105,217,000 | 82,863,000 | 69,878,000 | 89,023,000 | 80,875,000 | 53,927,000 | 55,864,000 | 58,615,000 | 58,539,000 | 60,501,000 | 62,157,000 | 65,089,000 | 67,921,000 | 76,885,000 | 77,273,000 | 78,211,000 | 76,826,000 | 76,726,000 | 74,471,000 | 60,218,000 | 22,558,000 | 18,906,000 | ||||||
goodwill and intangible assets | 14,977,000 | 15,443,000 | 15,933,000 | 16,479,000 | |||||||||||||||||||||||||||||||||||||
convertible note receivable | 7,254,000 | 7,192,000 | 7,130,000 | 7,067,000 | 7,004,000 | 6,942,000 | 6,879,000 | 6,816,000 | 6,753,000 | 6,691,000 | 6,629,000 | 6,566,000 | 6,503,000 | 6,441,000 | 6,379,000 | 6,316,000 | 6,253,000 | 6,191,000 | |||||||||||||||||||||||
operating lease right-of-use assets | 20,103,000 | 16,482,000 | 33,363,000 | 34,946,000 | 33,817,000 | 35,197,000 | 36,543,000 | 35,810,000 | 42,555,000 | 44,191,000 | 45,788,000 | 46,429,000 | 48,103,000 | 35,897,000 | 36,304,000 | 34,099,000 | 28,230,000 | 18,447,000 | 13,463,000 | 14,602,000 | 10,407,000 | 11,055,000 | 11,729,000 | 12,407,000 | 12,513,000 | 13,155,000 | |||||||||||||||
operating lease right-of-use assets, net – related parties | 14,620,000 | 15,298,000 | |||||||||||||||||||||||||||||||||||||||
other assets | 3,553,000 | 4,533,000 | 4,827,000 | 3,643,000 | 2,660,000 | 2,729,000 | 2,880,000 | 3,427,000 | 3,774,000 | 4,545,000 | 5,133,000 | 6,024,000 | 6,477,000 | 7,442,000 | 6,797,000 | 1,905,000 | 1,121,000 | 2,029,000 | 2,602,000 | 4,051,000 | 4,386,000 | 3,284,000 | 310,000 | 314,000 | 1,527,000 | 1,583,000 | 354,000 | 366,000 | 330,000 | 324,000 | 335,000 | 661,000 | 788,000 | 862,000 | 1,140,000 | 1,696,000 | 1,359,000 | 1,326,000 | 3,757,000 | ||
other assets – related parties | 433,000 | 378,000 | |||||||||||||||||||||||||||||||||||||||
total assets | 402,076,000 | 303,759,000 | 382,933,000 | 364,570,000 | 444,325,000 | 400,679,000 | 504,452,000 | 432,419,000 | 291,227,000 | 343,400,000 | 362,356,000 | 352,943,000 | 317,717,000 | 389,587,000 | 468,910,000 | 214,421,000 | 246,301,000 | 209,428,000 | 151,858,000 | 180,535,000 | 196,164,000 | 127,023,000 | 143,123,000 | 160,207,000 | 175,696,000 | 208,261,000 | 181,950,000 | 201,641,000 | 211,433,000 | 229,845,000 | 250,440,000 | 277,737,000 | 301,620,000 | 303,675,000 | 317,496,000 | 332,411,000 | 342,935,000 | 357,428,000 | 366,849,000 | 370,191,000 | 132,557,000 |
liabilities and stockholders’ deficit | |||||||||||||||||||||||||||||||||||||||||
current liabilities: | |||||||||||||||||||||||||||||||||||||||||
accounts payable | 7,419,000 | 13,501,000 | 6,725,000 | 9,945,000 | 20,317,000 | 13,869,000 | 9,195,000 | 19,818,000 | 25,488,000 | 33,573,000 | 21,016,000 | 20,237,000 | 18,053,000 | 9,832,000 | 11,418,000 | 15,120,000 | 19,153,000 | 20,097,000 | 4,101,000 | 6,160,000 | 3,971,000 | 3,148,000 | 1,749,000 | 2,115,000 | 1,927,000 | 2,804,000 | 2,793,000 | 3,525,000 | 5,502,000 | 3,566,000 | 5,865,000 | 9,485,000 | 4,271,000 | 4,280,000 | 4,045,000 | 2,245,000 | 3,303,000 | 1,105,000 | 2,085,000 | 4,947,000 | 3,180,000 |
accrued expenses and other liabilities | 35,705,000 | 27,889,000 | 40,580,000 | 43,596,000 | 35,344,000 | 32,712,000 | 42,708,000 | 64,871,000 | 62,335,000 | 54,118,000 | 41,825,000 | 46,220,000 | 52,351,000 | 62,468,000 | 51,387,000 | 38,519,000 | 36,134,000 | 36,793,000 | |||||||||||||||||||||||
operating lease liabilities | 3,682,000 | 3,876,000 | 7,466,000 | 7,033,000 | 6,249,000 | 6,082,000 | 5,244,000 | 4,363,000 | 5,984,000 | 2,844,000 | 2,650,000 | 1,365,000 | 1,404,000 | 3,507,000 | 3,011,000 | 3,072,000 | 2,430,000 | 5,156,000 | 5,500,000 | 5,351,000 | |||||||||||||||||||||
operating lease liabilities – related parties | 3,710,000 | 3,584,000 | |||||||||||||||||||||||||||||||||||||||
due to related parties | 128,000 | 355,000 | 173,000 | 386,000 | 200,000 | 1,096,000 | 1,136,000 | 1,272,000 | 1,159,000 | 2,932,000 | 3,469,000 | 3,018,000 | 4,158,000 | 5,595,000 | 3,943,000 | 8,697,000 | 16,711,000 | 17,817,000 | 5,269,000 | 1,356,000 | 2,228,000 | 853,000 | 486,000 | 868,000 | 957,000 | 1,531,000 | 1,696,000 | 2,175,000 | 1,806,000 | 2,456,000 | 2,363,000 | 1,986,000 | 2,216,000 | 2,124,000 | 1,753,000 | 1,853,000 | 1,727,000 | 1,674,000 | 1,352,000 | 610,000 | |
total current liabilities | 50,644,000 | 49,205,000 | 54,944,000 | 60,960,000 | 62,110,000 | 53,759,000 | 58,283,000 | 90,324,000 | 613,478,000 | 564,945,000 | 500,861,000 | 70,840,000 | 376,050,000 | 381,014,000 | 368,995,000 | 65,408,000 | 74,428,000 | 79,863,000 | 24,651,000 | 20,663,000 | 17,049,000 | 14,248,000 | 11,559,000 | 12,519,000 | 12,430,000 | 27,701,000 | 27,260,000 | 30,404,000 | 20,192,000 | 19,398,000 | 20,868,000 | 28,674,000 | 36,878,000 | 14,201,000 | 12,553,000 | 10,232,000 | 10,045,000 | 7,858,000 | 6,148,000 | 6,683,000 | |
related-party convertible note payable, at fair value | 492,084,000 | 485,717,000 | 461,877,000 | ||||||||||||||||||||||||||||||||||||||
revenue interest liability | 307,049,000 | 296,287,000 | 284,404,000 | 273,657,000 | 263,342,000 | 163,416,000 | 155,415,000 | ||||||||||||||||||||||||||||||||||
operating lease liabilities, less current portion | 20,798,000 | 17,077,000 | 34,823,000 | 36,761,000 | 36,427,000 | 38,199,000 | 39,942,000 | 39,313,000 | 44,558,000 | 46,289,000 | 47,951,000 | 49,561,000 | 50,648,000 | 36,251,000 | 37,068,000 | 34,642,000 | 29,116,000 | 16,554,000 | 9,814,000 | 11,250,000 | |||||||||||||||||||||
operating lease liabilities, less current portion – related parties | 15,042,000 | 16,020,000 | |||||||||||||||||||||||||||||||||||||||
derivative liabilities | 18,611,000 | 20,542,000 | 25,800,000 | 19,223,000 | 20,807,000 | 37,930,000 | 35,333,000 | ||||||||||||||||||||||||||||||||||
warrant liabilities | 66,957,000 | 9,023,000 | 8,575,000 | 18,308,000 | 65,395,000 | 109,987,000 | 118,770,000 | 39,370,000 | 27,799,000 | 17,780,000 | |||||||||||||||||||||||||||||||
other liabilities | 710,000 | 370,000 | 639,000 | 705,000 | 704,000 | 1,285,000 | 1,109,000 | 467,000 | 473,000 | 462,000 | 457,000 | 569,000 | 290,000 | 288,000 | 249,000 | 905,000 | 920,000 | 891,000 | 24,000 | 44,000 | 65,000 | 89,000 | 341,000 | 370,000 | 216,000 | 240,000 | 22,000 | 26,000 | |||||||||||||
total liabilities | 971,895,000 | 894,241,000 | 871,062,000 | 1,108,732,000 | 1,141,703,000 | 1,091,662,000 | 1,090,389,000 | 843,064,000 | 936,410,000 | 875,116,000 | 812,176,000 | 782,024,000 | 739,691,000 | 727,143,000 | 712,823,000 | 404,365,000 | 404,886,000 | 394,764,000 | 34,465,000 | 31,913,000 | 26,511,000 | 24,428,000 | 22,444,000 | 24,251,000 | 24,427,000 | 40,453,000 | 35,944,000 | 39,555,000 | 29,802,000 | 29,485,000 | 31,596,000 | 40,033,000 | 48,696,000 | 25,306,000 | 24,078,000 | 21,520,000 | 15,578,000 | 12,928,000 | 10,854,000 | 7,260,000 | 6,039,000 |
commitments and contingencies | |||||||||||||||||||||||||||||||||||||||||
stockholders’ deficit: | |||||||||||||||||||||||||||||||||||||||||
common stock | 91,000 | 85,000 | 85,000 | 70,000 | 69,000 | 68,000 | 67,000 | 67,000 | 44,000 | 43,000 | 42,000 | 40,000 | 40,000 | 40,000 | 40,000 | 39,000 | 39,000 | 38,000 | 11,000 | 11,000 | 11,000 | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 7,000 |
additional paid-in capital | 3,014,041,000 | 2,893,422,000 | 2,884,867,000 | 2,570,765,000 | 2,531,909,000 | 2,403,720,000 | 2,374,620,000 | 2,315,716,000 | 1,990,590,000 | 1,965,838,000 | 1,930,936,000 | 1,843,724,000 | 1,739,590,000 | 1,729,430,000 | 1,719,704,000 | 1,682,072,000 | 1,625,018,000 | 1,508,958,000 | 872,078,000 | 871,170,000 | 870,408,000 | 783,287,000 | 782,965,000 | 782,549,000 | 782,312,000 | 781,790,000 | 741,246,000 | 739,839,000 | 735,849,000 | 726,953,000 | 717,930,000 | 709,353,000 | 700,639,000 | 691,229,000 | 680,757,000 | 669,624,000 | 651,330,000 | 625,200,000 | 606,555,000 | 535,696,000 | 256,515,000 |
accumulated deficit | -3,597,449,000 | -3,504,894,000 | -3,375,248,000 | -3,316,086,000 | -3,230,357,000 | -3,095,793,000 | -2,961,684,000 | -2,728,292,000 | -2,632,710,000 | -2,494,831,000 | -2,378,488,000 | -2,270,273,000 | -2,159,335,000 | -2,064,747,000 | -1,961,921,000 | -1,870,662,000 | -1,783,033,000 | -1,694,745,000 | -754,574,000 | -722,442,000 | -700,666,000 | -680,574,000 | -662,191,000 | -646,550,000 | -630,969,000 | -613,786,000 | -594,981,000 | -577,413,000 | -553,778,000 | -526,046,000 | -498,713,000 | -471,455,000 | -447,486,000 | -412,628,000 | -387,063,000 | -358,876,000 | -324,405,000 | -281,026,000 | -250,376,000 | -172,723,000 | -130,004,000 |
accumulated other comprehensive income | 12,568,000 | 19,956,000 | 1,198,000 | 103,000 | -8,000 | -7,000 | 10,000 | 792,000 | -40,000 | -33,000 | 183,000 | -190,000 | -110,000 | -367,000 | 4,000 | 53,000 | 37,000 | -38,000 | 135,000 | 424,000 | 318,000 | ||||||||||||||||||||
total immunitybio stockholders’ deficit | -570,749,000 | -591,431,000 | -489,098,000 | -745,148,000 | -698,387,000 | -692,012,000 | -586,987,000 | -411,717,000 | -642,116,000 | -528,983,000 | -447,327,000 | -426,699,000 | -419,815,000 | -335,644,000 | -242,173,000 | -188,498,000 | -157,939,000 | -185,787,000 | |||||||||||||||||||||||
noncontrolling interests | 930,000 | 949,000 | 969,000 | 986,000 | 1,009,000 | 1,029,000 | 1,050,000 | 1,072,000 | -3,067,000 | -2,733,000 | -2,493,000 | -2,382,000 | -2,159,000 | -1,912,000 | -1,740,000 | -1,446,000 | -646,000 | 451,000 | |||||||||||||||||||||||
total stockholders’ deficit | -569,819,000 | -590,482,000 | -488,129,000 | -744,162,000 | -697,378,000 | -690,983,000 | -585,937,000 | -410,645,000 | -645,183,000 | -531,716,000 | -449,820,000 | -429,081,000 | -421,974,000 | -337,556,000 | -243,913,000 | -189,944,000 | -158,585,000 | -185,336,000 | |||||||||||||||||||||||
total liabilities and stockholders’ deficit | 402,076,000 | 303,759,000 | 382,933,000 | 364,570,000 | 444,325,000 | 400,679,000 | 504,452,000 | 432,419,000 | 291,227,000 | 343,400,000 | 362,356,000 | 352,943,000 | 317,717,000 | 389,587,000 | 468,910,000 | 214,421,000 | 246,301,000 | 209,428,000 | |||||||||||||||||||||||
marketable securities, noncurrent | 891,000 | 817,000 | 841,000 | 820,000 | 840,000 | 811,000 | 914,000 | 865,000 | 822,000 | 802,000 | 822,000 | 1,000,000 | 29,600,000 | 34,198,000 | 47,054,000 | 71,487,000 | 87,571,000 | 94,655,000 | 107,933,000 | 116,197,000 | 55,135,000 | ||||||||||||||||||||
related-party nonconvertible note, net of discount | 111,143,000 | 108,811,000 | 106,637,000 | 104,586,000 | |||||||||||||||||||||||||||||||||||||
related-party convertible notes and accrued interest, net of discount | 587,975,000 | 584,107,000 | 580,449,000 | 576,951,000 | 165,289,000 | 250,102,000 | 245,640,000 | ||||||||||||||||||||||||||||||||||
intangible assets | 16,058,000 | 16,572,000 | 17,093,000 | 18,467,000 | 18,992,000 | 19,502,000 | 20,471,000 | 21,738,000 | 22,349,000 | 565,000 | 1,130,000 | 1,695,000 | 2,260,000 | 2,826,000 | 3,391,000 | 3,956,000 | 4,521,000 | 5,086,000 | 5,948,000 | 6,396,000 | 6,844,000 | 7,292,000 | 7,164,000 | 7,620,000 | |||||||||||||||||
related-party promissory notes, net of discounts and deferred issuance costs | 481,894,000 | 441,628,000 | 431,901,000 | ||||||||||||||||||||||||||||||||||||||
related-party promissory notes, less current portion | 480,020,000 | 312,541,000 | 309,428,000 | ||||||||||||||||||||||||||||||||||||||
related-party convertible note payable at fair value | 28,281,000 | ||||||||||||||||||||||||||||||||||||||||
related-party convertible note at fair value | 36,618,000 | 29,850,000 | |||||||||||||||||||||||||||||||||||||||
intangible asset | 20,003,000 | 1,420,000 | 1,432,000 | 1,445,000 | 1,438,000 | ||||||||||||||||||||||||||||||||||||
investment and other assets | 4,860,000 | 6,775,000 | |||||||||||||||||||||||||||||||||||||||
related-party convertible notes and accrued interest, net of discount, less current portion | 241,271,000 | 287,761,000 | |||||||||||||||||||||||||||||||||||||||
warrant liability | 21,636,000 | ||||||||||||||||||||||||||||||||||||||||
related-party promissory note, net of deferred issuance costs | |||||||||||||||||||||||||||||||||||||||||
related-party promissory notes, net of discount, less current portion | 373,293,000 | ||||||||||||||||||||||||||||||||||||||||
related-party promissory notes, current portion | 300,084,000 | 299,612,000 | |||||||||||||||||||||||||||||||||||||||
deferred income tax liability | 162,000 | 162,000 | 170,000 | 170,000 | 170,000 | ||||||||||||||||||||||||||||||||||||
non-marketable equity investment | |||||||||||||||||||||||||||||||||||||||||
related-party notes payable | 299,236,000 | 303,240,000 | 300,252,000 | 297,286,000 | |||||||||||||||||||||||||||||||||||||
related-party notes payable, less current portion | 306,349,000 | ||||||||||||||||||||||||||||||||||||||||
deferred tax liability | 162,000 | 122,000 | 250,000 | 374,000 | 498,000 | 681,000 | 779,000 | 903,000 | 996,000 | 883,000 | 969,000 | 1,072,000 | 1,165,000 | ||||||||||||||||||||||||||||
marketable debt securities, available-for-sale | 54,772,000 | 61,353,000 | 7,925,000 | 23,263,000 | 36,144,000 | 47,766,000 | 66,773,000 | 76,270,000 | 57,328,000 | 67,998,000 | 88,822,000 | ||||||||||||||||||||||||||||||
marketable debt securities, noncurrent | 769,000 | 1,497,000 | 1,493,000 | 1,483,000 | 4,190,000 | 5,701,000 | 12,585,000 | 12,580,000 | 15,091,000 | ||||||||||||||||||||||||||||||||
equity investment | 7,849,000 | 9,253,000 | 9,253,000 | 9,253,000 | 9,253,000 | 8,500,000 | 8,500,000 | 8,500,000 | |||||||||||||||||||||||||||||||||
liabilities and stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||
accrued expenses | 8,343,000 | 5,497,000 | 7,449,000 | 6,634,000 | 5,343,000 | 5,251,000 | 6,466,000 | 20,242,000 | 21,104,000 | 22,785,000 | 11,517,000 | 12,077,000 | 11,267,000 | 15,838,000 | 14,381,000 | 6,858,000 | 5,864,000 | 5,910,000 | 4,724,000 | 4,716,000 | 2,575,000 | 1,126,000 | 2,618,000 | ||||||||||||||||||
other current liabilities | 1,438,000 | 2,299,000 | 3,401,000 | 3,613,000 | 3,981,000 | 4,285,000 | 3,080,000 | 3,124,000 | 1,667,000 | 1,919,000 | 1,367,000 | 1,299,000 | 1,373,000 | 1,365,000 | 1,130,000 | 939,000 | 891,000 | 224,000 | 291,000 | 363,000 | 136,000 | ||||||||||||||||||||
stockholders’ equity: | |||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive loss | -122,000 | -117,000 | -100,000 | -128,000 | -105,000 | -53,000 | -84,000 | -206,000 | -267,000 | -348,000 | -448,000 | -555,000 | -381,000 | -202,000 | -237,000 | -240,000 | -284,000 | -192,000 | -50,000 | ||||||||||||||||||||||
total stockholders’ equity | 117,393,000 | 148,622,000 | 169,653,000 | 102,595,000 | 120,679,000 | 135,956,000 | 151,269,000 | 167,808,000 | 146,006,000 | 162,086,000 | 181,631,000 | 200,360,000 | 218,844,000 | 237,704,000 | 252,924,000 | 278,369,000 | 293,418,000 | 310,891,000 | 327,357,000 | 344,500,000 | 355,995,000 | 362,931,000 | 126,518,000 | ||||||||||||||||||
total liabilities and stockholders’ equity | 151,858,000 | 180,535,000 | 196,164,000 | 127,023,000 | 143,123,000 | 160,207,000 | 175,696,000 | 208,261,000 | 181,950,000 | 201,641,000 | 211,433,000 | 229,845,000 | 250,440,000 | 277,737,000 | 301,620,000 | 303,675,000 | 317,496,000 | 332,411,000 | 342,935,000 | 357,428,000 | 366,849,000 | 370,191,000 | 132,557,000 | ||||||||||||||||||
operating lease liability, less current portion | 9,462,000 | 10,180,000 | 10,885,000 | 11,732,000 | 11,997,000 | 12,752,000 | |||||||||||||||||||||||||||||||||||
notes receivable, held-to-maturity | 723,000 | 723,000 | |||||||||||||||||||||||||||||||||||||||
financing obligation, less current portion | 5,945,000 | 6,108,000 | 6,267,000 | 1,663,000 | 1,741,000 | 1,814,000 | 1,885,000 | 1,955,000 | 2,025,000 | 2,390,000 | |||||||||||||||||||||||||||||||
deferred rent | 2,739,000 | 2,897,000 | 3,049,000 | 3,188,000 | 3,325,000 | 3,461,000 | 3,595,000 | 2,374,000 | 2,426,000 | 2,488,000 | 1,924,000 | 1,344,000 | 845,000 | 342,000 | |||||||||||||||||||||||||||
investment in equity securities | 9,253,000 | 9,253,000 | 9,251,000 | 8,500,000 | |||||||||||||||||||||||||||||||||||||
restricted cash | 250,000 | 1,200,000 | |||||||||||||||||||||||||||||||||||||||
stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||
build-to-suit liability, less current portion | 4,797,000 | 4,909,000 | 5,062,000 | 5,189,000 | 5,475,000 | 5,651,000 | 5,313,000 | 2,417,000 | 2,451,000 | ||||||||||||||||||||||||||||||||
note receivable, held-to-maturity | 361,000 | ||||||||||||||||||||||||||||||||||||||||
marketable debt securities | 110,593,000 | ||||||||||||||||||||||||||||||||||||||||
cost method investment | 8,500,000 | 8,500,000 | 8,500,000 | 8,500,000 | |||||||||||||||||||||||||||||||||||||
deferred revenue | 166,000 | 182,000 | 187,000 | 192,000 | 197,000 | 203,000 | 228,000 | 235,000 | 241,000 | ||||||||||||||||||||||||||||||||
financing obligation | 14,880,000 | ||||||||||||||||||||||||||||||||||||||||
property and equipment | 16,475,000 | 9,507,000 | 7,156,000 | 5,523,000 | 1,414,000 | 310,000 | |||||||||||||||||||||||||||||||||||
receivables, net, prepaid expenses and other current assets | 4,196,000 | 3,322,000 | |||||||||||||||||||||||||||||||||||||||
liabilities and stockholders' equity | |||||||||||||||||||||||||||||||||||||||||
build-to-suit lease liability, less current portion | 2,468,000 | ||||||||||||||||||||||||||||||||||||||||
stockholders' equity | |||||||||||||||||||||||||||||||||||||||||
class a common stock | |||||||||||||||||||||||||||||||||||||||||
investment in inex bio, inc. | |||||||||||||||||||||||||||||||||||||||||
notes payable | |||||||||||||||||||||||||||||||||||||||||
warrant derivative liability |
We provide you with 20 years of balance sheets for ImmunityBio stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ImmunityBio. Explore the full financial landscape of ImmunityBio stock with our expertly curated balance sheets.
The information provided in this report about ImmunityBio stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.